BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38787434)

  • 1. A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada.
    Tan VS; Tjong MC; Chan WC; Yan M; Delibasic V; Darling G; Davis LE; Doherty M; Hallet J; Kidane B; Mahar A; Mittmann N; Parmar A; Tan H; Wright FC; Coburn NG; Louie AV
    Support Care Cancer; 2024 May; 32(6):381. PubMed ID: 38787434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
    Tjong MC; Doherty M; Tan H; Chan WC; Zhao H; Hallet J; Darling G; Kidane B; Wright FC; Mahar A; Davis LE; Delibasic V; Parmar A; Mittmann N; Coburn NG; Louie AV
    Oncologist; 2021 Oct; 26(10):e1800-e1811. PubMed ID: 34216415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaps in the Management of Depression Symptoms Following Cancer Diagnosis: A Population-Based Analysis of Prospective Patient-Reported Outcomes.
    Hallet J; Davis LE; Isenberg-Grzeda E; Mahar AL; Zhao H; Zuk V; Moody L; Coburn NG
    Oncologist; 2020 Jul; 25(7):e1098-e1108. PubMed ID: 32100906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis.
    Tan VS; Tjong MC; Chan WC; Yan M; Delibasic V; Darling G; Davis LE; Doherty M; Hallet J; Kidane B; Mahar A; Mittmann N; Parmar A; Tan H; Wright FC; Coburn NG; Louie AV
    Curr Oncol; 2023 Mar; 30(3):3461-3472. PubMed ID: 36975475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyspnea in patients with stage IV non-small cell lung cancer: a population-based analysis of disease burden and patterns of care.
    Yan M; Tjong M; Chan WC; Darling G; Delibasic V; Davis LE; Doherty M; Hallet J; Kidane B; Mahar A; Mittmann N; Parmar A; Tan V; Tan H; Wright FC; Coburn NG; Louie AV
    J Thorac Dis; 2023 Feb; 15(2):494-506. PubMed ID: 36910044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trajectories of Health Care Contact Days for Patients With Stage IV Non-Small Cell Lung Cancer.
    Gupta A; Nguyen P; Kain D; Robinson AG; Kulkarni AA; Johnson DH; Presley CJ; Blaes AH; Rocque GB; Ganguli I; Booth CM; Hanna TP
    JAMA Netw Open; 2024 Apr; 7(4):e244278. PubMed ID: 38587847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non-small-Cell Lung Cancer.
    Dawe DE; Pond GR; Ellis PM
    Clin Lung Cancer; 2016 Nov; 17(6):563-572.e2. PubMed ID: 27374398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rurality, Stage-Stratified Use of Treatment Modalities, and Survival of Non-small Cell Lung Cancer.
    Ray MA; Faris NR; Derrick A; Smeltzer MP; Osarogiagbon RU
    Chest; 2020 Aug; 158(2):787-796. PubMed ID: 32387525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Rurality With Survival and Guidelines-Concordant Management in Early-stage Non-Small Cell Lung Cancer.
    Nicoli CD; Sprague BL; Anker CJ; Lester-Coll NH
    Am J Clin Oncol; 2019 Jul; 42(7):607-614. PubMed ID: 31232724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.
    Wu SY; Lazar AA; Gubens MA; Blakely CM; Gottschalk AR; Jablons DM; Jahan TM; Wang VEH; Dunbar TL; Wong ML; Chan JW; Guthrie W; Belkora J; Yom SS
    JAMA Netw Open; 2020 Sep; 3(9):e209750. PubMed ID: 32997124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe symptoms persist for Up to one year after diagnosis of stage I-III lung cancer: An analysis of province-wide patient reported outcomes.
    Hirpara DH; Gupta V; Davis LE; Zhao H; Hallet J; Mahar AL; Sutradhar R; Doherty M; Louie AV; Kidane B; Darling G; Coburn NG
    Lung Cancer; 2020 Apr; 142():80-89. PubMed ID: 32120228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
    McGee SF; Zhang T; Jonker H; Laurie SA; Goss G; Nicholas G; Albaimani K; Wheatley-Price P
    Clin Lung Cancer; 2018 Jan; 19(1):e91-e99. PubMed ID: 28666762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world treatment patterns and survival in stage IV non-small-cell lung cancer in Canada.
    Seung SJ; Hurry M; Walton RN; Evans WK
    Curr Oncol; 2020 Aug; 27(4):e361-e367. PubMed ID: 32905294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
    Saw SPL; Zhou S; Chen J; Lai G; Ang MK; Chua K; Kanesvaran R; Ng QS; Jain A; Tan WL; Rajasekaran T; Lim DWT; Tan A; Fong KW; Takano A; Cheng XM; Lim KH; Koh T; Ong BH; Tan EH; Toh CK; Skanderup AJ; Tan SH; Tan DSW
    JAMA Netw Open; 2021 Nov; 4(11):e2131892. PubMed ID: 34739062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residence in Rural Areas of the United States and Lung Cancer Mortality. Disease Incidence, Treatment Disparities, and Stage-Specific Survival.
    Atkins GT; Kim T; Munson J
    Ann Am Thorac Soc; 2017 Mar; 14(3):403-411. PubMed ID: 28118039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaps in Depression Symptom Management for Patients With Head and Neck Cancer.
    Noel CW; Sutradhar R; Chan WC; Fu R; Philteos J; Forner D; Irish JC; Vigod S; Isenberg-Grzeda E; Coburn NG; Hallet J; Eskander A
    Laryngoscope; 2023 Oct; 133(10):2638-2646. PubMed ID: 36748910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?
    Sacher AG; Le LW; Lau A; Earle CC; Leighl NB
    Cancer; 2015 Aug; 121(15):2562-9. PubMed ID: 25891153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study.
    Wong ML; McMurry TL; Stukenborg GJ; Francescatti AB; Amato-Martz C; Schumacher JR; Chang GJ; Greenberg CC; Winchester DP; McKellar DP; Walter LC; Kozower BD
    Lung Cancer; 2016 Dec; 102():108-117. PubMed ID: 27987578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and predictors of Quality of Life in lung cancer survivors.
    Bade BC; Zhao J; Li F; Tanoue L; Lazowski H; Alfano CM; Silvestri GA; Irwin ML
    Lung Cancer; 2024 May; 191():107793. PubMed ID: 38640687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.